The European Cancer Organisation aims to create and develop ever-strengthening relationships between European institutions and the European cancer care community, and together with our Member Societies, Patient Advisory Committee and networks, facilitate collaboration and consensus on focused topics towards tangible and impactful policy improvement.
The strategic objectives that underpin all our policy activity are:
Read more about our policy approval pathway here.
Reach Higher for Cancer Care is an advocacy campaign led by the European Cancer Organisation to ensure that cancer remains a political and financial priority in the EU’s next long-term budget for 2028 to 2034.
At a time when the proposed Multiannual Financial Framework (MFF) risks diluting the dedicated focus created by Europe’s Beating Cancer Plan and EU4Health, the campaign calls on EU institutions and member states to safeguard progress by securing sustained and visible investment in cancer control, research and equitable access to care.
By uniting healthcare professionals, patients, survivors, researchers, policymakers and industry, Reach Higher for Cancer Care seeks to protect momentum, strengthen coordination of cancer research, reduce disparities across countries, and ensure that Europe continues to invest ambitiously in prevention, treatment, workforce capacity and innovation.
The European Cancer Pulse is a unique data visualisation tool designed to track inequalities and monitor progress in cancer care across Europe, highlighting the factors that influence disparities in cancer care.
read moreNational & European Parliamentarians for Cancer Action brings together more than 130 relevant policymakers to design better cancer policies in Europe, learn from best practices across the cancer care continuum, and collectively create data-driven recommendations in the fight against cancer. You can find a list of the members below.
read moreFebruary 2026
Today, the European Parliament has urged Member States and the European Commission to renew their political commitment to the full implementation of Europe’s Beating Cancer Plan for the seven years covered by the next EU multi-annual budget.
Read moreDecember 2025
Ireland will assume the rotating Presidency of the Council of the European Union in July. As such, Irish representatives will have a unique opportunity to place cancer firmly on the EU agenda and to strengthen European cooperation in cancer prevention, research, care and survivorship in the years to come.
Few countries are better versed in the challenges and opportunities.
Read moreDecember 2025
Cancer is responsible for an estimated €49 billion in productivity losses in the EU every year. Without stronger action, cancer is expected to cause one in four premature deaths in the EU by 2050. The strain on health systems, families, and national economies will be severe.
Read moreOctober 2025
The Association of European Cancer Leagues (ECL) and the European Cancer Organisation (ECO) are calling on EU economic and finance ministers, meeting in the Economic and Finance Affairs Council this Friday, to support the fight against cancer by endorsing the proposal for a Tobacco Excise Duty Own Resources (TEDOR) and the revision of the Tobacco Taxation Directive (TTD).
Read moreSeptember 2025
Three upcoming European Commission strategies on equality could play a decisive role in advancing health equity: The EU Gender Equality Strategy, the EU Anti-racism Strategy, and EU LGBTIQ Equality Strategy.
Read moreJuly 2025
The European Cancer Organisation (ECO) applauds the European Commission’s proposal this month to revise the Tobacco Taxation Directive, an important step to further tobacco control policies across the European Union (EU).
Read moreJuly 2025
Today, the European Commission has published its proposal for the 2028-2034 Multiannual Financial Framework. The long-term budgets of the European Union are not just about funding, but also about policies and strategies. The proposal is followed by roughly one year in which negotiators will need to agree on a final framework.
Read moreJuly 2025
Europe can achieve its goal of eliminating cancers caused by the human papillomavirus (HPV) by delivering 3 key policies, among others: universal HPV vaccination; reliable data systems to track vaccine uptake and drive policy impact; and greater access to HPV and cervical cancer and HPV screening.
Read moreApril 2025
World Immunization Week 2025 (24–30 April) is a campaign led by the World Health Organization to highlight the life-saving power of vaccines.
At the European Cancer Organisation, we are proud to support this initiative by raising awareness of the critical role of HPV and hepatitis B vaccination in cancer prevention. These vaccines are among the most effective tools we have in the fight against seven different cancers.
Read moreApril 2025
The European Cancer Organisation responds to the SANT Consultation
A call for gender-sensitive EU action
The European Cancer Organisation (ECO) has submitted its formal response to the European Parliament’s Public Health Subcommittee (SANT) consultation on women’s health — urging lawmakers to address the unacceptable gender gaps in cancer care.
Read moreWe promote and believe in collaboration as a matter of principle. This high level co-operation should exist between oncology healthcare professionals of different disciplines, between health care sectors and with a wider group of stakeholders in public health.
As part of our Mission and Vision, we work as active members of the following alliances:
To reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, through multidisciplinarity and multiprofessionalism.
As the not-for-profit federation of member organisations working in cancer at a European level, we convene oncology professionals and patients to agree policy, advocate for positive change and be the united voice of the European cancer community.
To be a vibrant, pro-active, focused, relevant and influential federation, working together for a cancer free future, ensuring that every patient has high quality care and treatment, with access to the full range of professionals needed.
To create and develop ever-strengthening relationships between European institutions and the European cancer care community, and with our Member Societies, Patient Advisory Committee and Focused Topic Networks, facilitate collaboration and consensus towards tangible and impactful policy improvement.
Our essential and enduring values are:
In the early 1980s, a few European visionaries working in oncology laid the groundwork for multidisciplinarity in cancer care, entailing that tackling cancer was a team effort that required a coordinated approach. It was a relatively new concept at the time, but 40 years later, multidisciplinarity is viewed as the best approach to cancer treatment.
It was consequently decided to bring together major players in cancer research, treatment, and care in order to create awareness of patients’ wishes and needs, encourage progressive thinking in cancer policy, education, and training, and continue to promote European cancer research and its application through the organisation of a multidisciplinary conference called ECCO - the European Conference on Clinical Oncology (later renamed ECCO-the European Cancer Conference). To strengthen and further develop these ideas, in 1981 six professional societies, ESMO, ESTRO, ESSO, EACR, EONS, SIOPE legally founded FECS (Federation of European Cancer Societies).
After a period of reflection in 2006 and 2007, during which many players in oncology were consulted, FECS was transformed into a new dynamic entity: the European Cancer Organisation. This was officially announced at the European Cancer Conference in Barcelona in September 2007, where the organisation was launched under its new name.
Read our full story here.
Find out more about our Strategy for 2024-2027 here.